Miki
Lv3
330 积分
2023-07-08 加入
-
PT01.2: ZP7570: A Novel GLP-1/GLP-2 Dual Acting Peptide with Potential as the Next Generation Therapy for Short Bowel Syndrome
4天前
已完结
-
Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesity
4天前
已完结
-
T Cell Exhaustion
9天前
已完结
-
Pharmacokinetics, pharmacodynamics, and tolerability of JY09 in healthy Chinese subjects: A titrating, dose-escalating study
10天前
已完结
-
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
10天前
已完结
-
Safety, Tolerability and Pharmacokinetics of Single Dose Polyethylene Glycolated Exenatide Injection (PB-119) in Healthy Volunteers
10天前
已完结
-
Safety, Pharmacokinetics and Pharmacodynamics of Multiple Escalating Doses of PEGylated Exenatide (PB-119) in Healthy Volunteers
10天前
已完结
-
Safety, tolerability, pharmacodynamics and pharmacokinetics of CJC-1134-PC in healthy Chinese subjects and type-2 diabetic subjects
11天前
已完结
-
Treatment of type 2 diabetes: challenges, hopes, and anticipated successes
13天前
已完结
-
Distribution of GLP-1 and PACAP receptors in human tissues
13天前
已完结